Development of novel nucleic acid-loaded Bubble liposomes using cholesterol-conjugated siRNA

J Drug Target. 2011 Nov;19(9):830-6. doi: 10.3109/1061186X.2011.585428. Epub 2011 Jun 13.

Abstract

Recently, we developed polyethyleneglycol (PEG)-modified liposomes (Bubble liposomes; BLs) entrapping ultrasound (US) gas and reported that the combination of BLs and US exposure was an effective tool for the delivery of siRNA directly into cells and US-exposed tissues within a short period; however, the results were obtained using a mixture of BLs and naked siRNA. With systemic injections, it is important to control the biodistribution of both BLs and siRNA. In addition, the delivery of siRNA is affected by nuclease degradation and rapid removal from the circulation after intravenous administration. In this study, we attempted to prepare novel siRNA-loaded BLs (chol-si-BLs) using cholesterol-conjugated siRNA (chol-siRNA). We demonstrated that chol-siRNA could be loaded into BLs, leading to the stability of siRNA even in the presence of an RNase. The specific gene-silencing effect was also achieved by transfection with chol-si-BLs and US. Thus, the combination of chol-si-BLs with US exposure is expected to deliver siRNA into a specific tissue via systemic injection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • Cholesterol / chemistry*
  • Gene Silencing
  • Liposomes
  • Microbubbles*
  • RNA, Small Interfering / administration & dosage*
  • Ribonucleases / metabolism
  • Time Factors
  • Tissue Distribution
  • Transfection
  • Ultrasonography / methods*

Substances

  • Liposomes
  • RNA, Small Interfering
  • Cholesterol
  • Ribonucleases